3 Simple Longevity Rules A Nobel Prize Winner Swears By
Reassuringly, simple, conventional advice about staying on top of your heart health and getting in tune with your body clock might help you to boost your odds of a longer life.
Speaking to Vatican News, biologist and winner of the 2009 Nobel Prize in Chemistry, Dr. Venkatraman Ramakrishnan, says he follows three such rules to improve his own longevity.
Dr Ramakrishnan, who has written a book called Why We Die, says he, 'came to the conclusion that the trio of a moderate and healthy diet, regular exercise, and adequate sleep is probably better than anything out on the market today in terms of supplements or drugs.'
He adds that avoiding social isolation probably helps, too.
Those pearls of wisdom might seem a little well-worn compared to the shiny, controversial experiments with longevity people like Bryan Johnson get involved with – but they're much better backed.
The American Medical Association says that working out two to four times above the recommended amount is associated with a 26-31% decrease in all-cause mortality.
A paper published in Nature says that improving UK diets could lead to 10 years more life.
And 2024 research found that men who sleep well live, on average, five years longer than those who don't.
'We're at a crossroads in terms of where we are in terms of life expectancy,' Dr Ramakrishnan told the publication at the Vatican Longevity Summit this year.
'Biology has made great strides in understanding the causes of ageing and for the first time is trying to see if we can do something about tackling ageing itself as opposed to tackling specific diseases.'
While this makes him wonder 'what will it mean for society if we all start living longer', he adds that his advice should work as well for the Pope (the longevity summit was held at the Vatican) as it does the rest of us.
'As [the Pope] gets better, the trio that I suggested would work for him, just as it would for anybody else,' the Nobel prize winner ended.
10 Everyday Habits That Are Harming Your Longevity The Most
I'm A Longevity Expert – This 30-Second Test May Reveal Your Risk Of Early Death
I'm A Longevity Professor – These 3 Walking Rules Can Help You Live Longer
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Could UK Tap Water's 'Forever Chemicals' Lead To France-Style Bans?
France has seen its biggest ever ban on tap water in Saint-Louis, near the Swiss city of Basel. Local authorities put letters through approximately 60,000 mailboxes urging the public to ensure that kids under two, pregnant and breastfeeding people, and the immunocompromised don't drink tap water. This was because the levels of PFAs, also known as 'forever chemicals,' had been raised to four times the acceptable limit by firefighting foam used in a local airport since the '60s. PFAS stand for per- and polyfluoroalkyl substances, chemicals which take an extremely long time to break down. They're present in everything from skincare products to frying pans and include 5,000+ substances. Saint-Louis is one of thousands of EU water sources suspected to be contaminated by too many PFAs, the overconsumption of which may be linked to increased cancer risk, reproductive issues, compromised immune systems, and even heightened cholesterol levels. Given that 'from 2018 to 2022, 51-60% of rivers, 11-35% of lakes and 47-100% of transitional and coastal waters exceeded the annual average environmental quality standards (EQS) for PFOS [a specific PFAS]' in Europe, we thought we'd ask what that might mean for the UK. Speaking to HuffPost UK, Professor Sir Colin Berry, Emeritus Professor of Pathology at the Queen Mary University of London, offered some reassurance. 'It is worth emphasising the reason that these compounds [PFAS] are persistent is that they are non-reactive; the chances that the very small amounts found will have detectable adverse effect if ingested is vanishingly small,' the former President of the European Society of Pathology told us. 'The levels are set as precautionary values and are more to do with control of contamination than concern about health,' he added. The Drinking Water Inspectorate says that, 'Based on our current knowledge, the low levels of PFAS detected in some untreated water abstracted for public drinking water supplies has no acute or immediate impact on human health.' Still, a 2023 evaluation by the World Health Organisation concluded that teo PFAS (perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS)) can be considered carcinogenic and possibly carcinogenic, respectively. PFOAs are group 1 carcinogens per the WHO's cancer research sector, IARC, along with processed meat, tobacco, and asbestos. PPOS are group 2B 'possible' carcinogens, along with aloe vera, coconut oil, and pickled vegetables. Doctors have previously criticised the IARC cancer grouping system for not considering 'the level of risk relative to the dosage,' which they think may have led to the body grouping things like salted fish in the same group 1 carcinogen class as plutonium. Whatever the disputed effects of going over the EU's limit of PFAS may be, Dr Shubhi Sharma, a Scientific Research Assistant at CHEM Trust, says parts of the UK certainly do that. 'PFAS have already been found in almost 200 untreated drinking water samples in England and the levels in these samples were found to be above the Drinking Water Inspectorate's PFAS threshold guidance for England and Wales, which is a 'wholesomeness' value of 0.1 ug/l for 48 PFAS,' she told us. A Ministry of Defence spokesperson told The Guardian in response to those claims that 'Ensuring the safety of our staff, personnel and the public is our number one priority and that's why we are complying with the relevant legislation and regulations. 'As understanding of these chemicals has changed, we have responded accordingly. We have prioritised a programme of investigation of our sites, which has been agreed with the Environment Agency.' The CHEM Trust researcher said England and Wales 'have no statutory limits on PFAS in drinking water – the water companies just need to test for 48 PFAS, but this is a non-binding guidance. Scotland, on the other hand, adheres to EU standards, which are far stricter than the UK guidelines.' Member states of the EU, she added, will need to comply with the Drinking Water Directive thresholds by 12th January 2026. 'People in [the] UK have different threats of exposure to PFAS in their drinking water depending on whether they live in Scotland or England/Wales,' Dr Sharma added. Dr Sharma, who believes PFAS carry health risks and are a 'huge concern,' says that 'the UK needs to regulate PFAS as a group and at the very source' (mainly industrial sites). But seeing as England and Wales have no statutory limit on PFAS and Scotland sticks to the EU-recommended level, a tap water ban based on the slow-degrading chemicals seems unlikely any time soon. The Next Thing To Ruin The UK's Water Supply Isn't What You Think Tories Shamed Over UK's Polluted Water Supply: 'They Turned A Blind Eye' I've Dreaded Every Heatwave Since 2019 – And It's Only Going To Get Worse
Business Wire
a day ago
- Business Wire
Alume Biosciences Announces Publication of Data Examining First-in-Human Use of Bevonescein to Illuminate Nerves in Nature Communications
SAN DIEGO--(BUSINESS WIRE)--Alume Biosciences, a late-clinical stage biotechnology company developing nerve-illuminating technology to enhance surgical safety, today announced the publication of first-in-human data from a Phase 1 clinical trial evaluating bevonescein (ALM-488) in head and neck surgeries. The original research article titled, ' Intraoperative Nerve-Specific Fluorescence Imaging in Head and Neck Surgery: A Phase 1 Clinical Trial,' authored by Lee, Y., Orosco, R., et al., was published in Nature Communications. 'These data support our belief that bevonescein can help make surgery more precise by allowing surgeons to see nerves more clearly." Bevonescein is a novel fluorescent visualization drug designed to selectively illuminate nerves during surgery, helping to prevent inadvertent nerve injury and is currently being evaluated in ongoing Phase 3 clinical trials. 'Currently, many head and neck surgeries result in nerve injuries, which can be catastrophic for the patients,' said Eben L. Rosenthal, MD, Barry Baker Professor and Chair of the Department of Otolaryngology–Head and Neck Surgery at Vanderbilt University Medical Center and study senior author. 'This first-in-human data demonstrate the safety of bevonescein and its potential to enhance nerve visualization in real time. It's especially promising to see improvements in nerve conspicuity at the optimal dose.' Key Findings: Fluorescence Superiority: Bevonescein provided enhanced nerve visualization with higher nerve conspicuity scores in fluorescent compared to white light. All participants demonstrated improved visible nerve length; 57% showed more than 20% improvement. Optimal Dose Defined: The optimal treatment dose of bevonescein was 500mg. Favorable Safety Profile: No dose-limiting toxicities or infusion reactions occurred. No surgeries were delayed or canceled due to the study drug. 'These data support our belief that bevonescein can help make surgery more precise by allowing surgeons to see nerves more clearly,' said Quyen Nguyen, MD, PhD, Founder and CEO of Alume Biosciences. 'When Roger Tsien and I started work on bevonescein, our vision was to translate his Nobel Prize-winning discoveries regarding fluorescence into tools that directly improve surgical outcomes. This milestone brings us closer to that goal.' 'With the growing adoption of fluorescence guidance in surgery, it's exciting to see this technology now applied to nerve identification,' said Ryan Orosco, MD, Associate Professor, University of New Mexico and the study's co-lead author. 'Bevonescein represents a paradigm shift in how we identify nerves during surgery, and ultimately how we improve patient outcomes.' Study Overview The dose-defining and dose-timing clinical trial enrolled 27 adults undergoing elective head and neck surgery including parotidectomy, thyroidectomy and cervical neck dissections. Participants received intravenous bevonescein at varying doses to assess safety, pharmacokinetics, and optimal visualization timing. Surgical visualization of bevonescein-enabled nerve fluorescence was performed using the Zeiss Tivato surgical microscope with Yellow 560. Surgeons assessed nerve visualization using 4-point Likert scale that measured conspicuity, visible nerve length, and delineation of branching. About Bevonescein (ALM-488) Bevonescein is Alume's lead compound—a targeted fluorescent peptide-dye conjugate that binds to nerve tissue, enabling intraoperative nerve visualization. It is currently in Phase 3 clinical trials and is planned for New Drug Application (NDA) submission to the U.S. Food and Drug Administration in 2026. About Alume Biosciences Alume Biosciences is a biotechnology company pioneering nerve-targeted drugs to enhance surgical precision and preserve nerve function. Founded on a lead candidate co-invented by late Nobel Laureate Dr. Roger Tsien, Alume is committed to translating cutting-edge science into practical tools for surgeons and better outcomes for patients. Learn more at and LinkedIn.
Fast Company
a day ago
- Fast Company
I'm an emergency doctor who knows burnout firsthand. Here's why every industry should be paying attention
One of medicine's harder lessons about burnout and mental health might be the most urgently needed by every industry right now. As an emergency physician who also did four years of surgical residency training, I witnessed firsthand how the grueling training that medical residents face, coupled with a tough-it-out attitude, can cause silent suffering—and sometimes with deadly consequences. Often it is the institutional stigma that prevents doctors from seeking help. Physician burnout is a systemic, not individual, failure, and its prevalence has been growing. According to the American Medical Association (AMA), the pandemic increased physician burnout to an all-time high, due to the grief, isolation, and psychological pressures. Physician Suicide: The Tip of the Iceberg Studies show physician suicides are among the highest of any profession. For men, it's 40% higher than the general population, and for women, it's up to 130% higher. Seeking mental health support is still seen as a risk—not to our well-being, but to our careers. Often there are fears of career consequences if we speak candidly about our mental health. Plus, issues related to licensing and credentialing processes often exacerbate this silence. Inside the industry, there's the subtle implication that physicians with any mental health issue might not be fit to practice. And it's a tragic irony, as we spend our careers advocating for our patients' mental health but often are too afraid to address our own. ER Violence: Another Burnout Contributor Burnout isn't only due to emotional exhaustion and stress. It can also be fueled by daily threats and obstacles that can strip away our dignity. Violence against healthcare staff, especially in emergency departments, is escalating. A 2024 poll from the American College of Emergency physicians (ACEP) found more than 90% of emergency physicians report being threatened or attacked in the past year. These incidents carry more than physical harm: 85% of physicians cite emotional trauma and anxiety, and 89% say their productivity has been impacted by it. Every assault is another blow to the emotional well-being of physicians, as well as affecting the quality of care for patients, too. And it shows up beyond medicine, too: in industries where plenty physical labor is involved—say, service, hospitality, or event execution—a lack of safety protocols can knock down emotional well-being for workers. Insurance Battles: An Administrative Avalanche Healthcare professionals spend up to two hours on clerical work for every clinical hour, driven largely by paperwork, billing, and prior authorizations, which has increased steadily over time. According to an AMA survey, this added burden of prior authorization is contributing to physician burnout. But additionally, we also worry about pre-authorization and its often-associated denials. About 94% of medical professionals surveyed reported it negatively impacts patient care. Excessive administrative work and burden is strongly correlated with burnout, but also stress-related health problems. And it's not only in healthcare: it's also seen in plenty of other industries, from finance to business to tech. Resilience Culture: Shifting Leadership from Stoic to Supportive In healthcare 'resilience' is seen as a badge of honor, entailed by pushing through grueling shifts, making life-or-death decisions, and walking out with a composed face. But true resilience is built on having support, empowerment, and trust. Resilience does not mean invulnerability. But medicine's history has taught us that psychological safety matters more than invulnerability. Creating a psychologically safe environment—where people feel safe to speak up, take risks, and be vulnerable without fear of negative consequences—is more important than maintaining a facade of control. In healthcare, psychological safety is crucial for open communication, error reporting, and team collaboration, ultimately benefiting patient care. And it applies to every industry. Credibility in leadership cannot be built on denial of stress; teams led by emotionally intelligent, vulnerable leaders perform better. Trauma-informed care is a model that originated in medicine and mental health but has profound implications for any workplace. It prioritizes trust, empathy, and empowerment, thereby improving outcomes for patients and providers alike. It influences how individuals interact, communicate, and respond to challenges at work. Adopting trauma-informed principles of safety, empowerment, and collaboration can benefit any workplace, replacing isolation with solidarity. Small Shifts with Big Impact Corporations, law firms, schools, and more could learn from emergency departments. It's important to acknowledge risks, measure physical and emotional safety, empower employees to help shape the system, and make sure your leaders are connected to their people. Burnout is not a character flaw. It's an organizational and occupational hazard. When violence, paperwork, and isolation compound high-stakes fields, emotional safety can be the difference between thriving or breaking. Medicine is slowly proving it's possible to change through systemic redesign. We don't need more heroes who suffer in silence. We need systems that listen, leaders who care, and cultures that heal instead of harm. If medicine, one of the most tradition-bound professions, can begin to change, so can everyone else.
